PPCB · Propanc Biopharma, Inc.
AI read · Bad for PPCB
The AI's read
The supplied share price is above the $1 minimum, and Propanc says it believes it fixed the shortfall. But Nasdaq says a recent reverse split bars the usual time to fix it. An appeal would pause removal for review, yet Nasdaq has not ruled on the matter. The risk to its listing remains.